drugset / Trial / NCT02653638

Summary

Cerebral vasodilator responses to CO2 will be measured in young healthy adults, healthy sedentary older adults, and healthy exercise trained older adults. This variable will be examined before and after administering the cyclooxygenase inhibitor indomethacin, which has been shown to blunt cerebral vasodilator responses. In addition, the investigators will examine these counter-regulatory hemodynamic mechanisms to hypoperfusion caused by indomethacin.

Timeline

Start
2016-06
Primary completion
2019-04
Completion
2019-04

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Indomethacin Small molecule 1.2 mg/kg Oral